News for hackers. Stuff that matters.
Re:‘Pharmacy of the developing world’ under attack from the ... by emodendroket on Tuesday August 25, 2015 @03:33PM (#10118954)
Come on. The scientists are not seeing the lion's share of the money from sky-high drug prices (and besides that, you can see some plainly opportunistic moves like recategorizing drugs to raise the fees that don't have anything whatsoever to do with new research).
Re:‘Pharmacy of the developing world’ under attack from the ... by pinaceae on Tuesday August 25, 2015 @03:50PM (#10119036)
scientist/founders do, see practically all bio-tech startups.

exactly the same as in tech - founders reap the big rewards, individual coders less so.

Re:‘Pharmacy of the developing world’ under attack from the ... by pen2l on Thursday August 27, 2015 @04:16AM (#10128182)
In my circle of friends at least, PhDs working on various technologies had their names on patents. When big companies bought these patents, they actually received good money. Not retirement money of course, but a few good tens of thousands.
Re:‘Pharmacy of the developing world’ under attack from the ... by mercurial on Tuesday August 25, 2015 @04:04PM (#10119105)
How many of these cancer drugs are made by bio-tech startups, exactly?
Re:‘Pharmacy of the developing world’ under attack from the ... by danielweber on Tuesday August 25, 2015 @05:58PM (#10119723)
These don't break it down by "start-up" but:

http://pipeline.corante.com/archives/2010/11/04/where_drugs_...

58% from pharmaceutical companies.

18% from biotech companies..

16% from universities, transferred to biotech.

8% from universities, transferred to pharma.

Pharma and biotech companies do develop some drugs themselves, but the majority model is for a start-up to form around a single drug, and if it looks promising a big player buys them up to finish testing and then market it. If the drug looks promising the company is killed.

Venture capital is basically doing the job of drug discovery.